Clinical Research
Genitourinary Surgical Consultants is owned by Dr. Jeffrey A. Snyder. Both he and Cynthia Ehret, PA-C, act as investigators for various clinical trials. The research department is conveniently located within the clinical office or Dr. Jeffrey A. Snyder.
The clinical department shares patient names with the research department and as a patient of Genitourinary Surgical Consultants you may receive periodic information from our research department about studies which may be of interest to you and/or that your physician has recommended.
Why are Clinical Studies important to Genitourinary Surgical Consultants?
Being involved in research programs helps our office meet its' mission to serve women and men who want to remain active and youthful by empowering them to regain control over their urinary, pelvic and sexual health. Through this association, we are able to offer a wide variety of treatment options and remain on the cutting edge of technology.
What is a Clinical Study?
A Clinical Study is designed to test the effects of a medication, medical treatment or device on a group of volunteers. A group of professionals called the Institutional Review Board or IBR carefully review study activities and is responsible for the safety and well-being of the study volunteers.
Who can be in a Clinical Study?
People with the condition being studied as well as healthy people can volunteer to participate in clinical studies. Each study has specific requirements for participants. The Principle Investigator conducting the study will review the volunteer's medical history and study requirements to determine eligibility. Study procedures, benefits and known risks will be explained to the volunteer prior to participating in the study. This discussion is called the Informed Consent.
What are the benefits of volunteering?
Several benefits exist for the volunteer. These include:
At this time we are currently recruiting patients for the following studies:
If you have any of these conditions, you may be eligible to participate in a clinical trial. If you're interested in being screened, please contact 303.320.0120.
Below are research studies we are currently recruiting for.
Males aged 45 years old and up with symptoms of BPH for at least 1 year. Symptoms include a diminished flow rate, frequently getting up in the night to urinate, hesitancy and straining while urinating, dribbling after urination, and feeling of incomplete bladder emptying. This study drug is a one time injection into the prostate. Subjects cannot have had any surgical treatments for their BPH such as greenlight/PVP laser, TURP, TUMT, TUNA etc. If subjects are on medications to treat BPH, they would need to stop them prior to randomizing into the study. Patients on blood thinners/NSAIDs would have to stop them 5 days before the injection. Subjects cannot have had prostatitis in the last 6 months. Study runs for 1 year.
Males aged 50 years of age or older with symptoms of BPH for at least 6 months. Symptoms include a diminished flow rate, frequently getting up in the night to urinate, hesitancy and straining while urinating, dribbling after urination, and feeling of incomplete bladder emptying. Drug is administered once via subcutaneous injection. Subjects must discontinue any medication they are currently taking to treat BPH. Subjects cannot have had any surgical treatments for their BPH such as greenlight/PVP laser, TURP, TUMT, TUNA etc. Cannot have had diagnosed cancer within the last five years. Study runs for 1 year.
Females and Males aged 18 years of age or older with symptoms of idiopathic Overactive Bladder with urinary incontinence whose symptoms have not been adequately managed with anti-cholinergic therapy. Subjects would receive an injection of Botox® into the bladder wall. If taking medication to treat OAB, the subjects would need to discontinue use of medication prior to randomization. Subjects must experience at least 3 episodes of urinary urgency incontinence on average in a 24 hour period. Subject cannot have a history of bladder or prostate cancer. Subjects cannot have had more than 2 UTI's in the last 6 months.